Is a modest drop in sperm concentration from 55 to 43 million per milliliter over two months, with normal follicle‑stimulating hormone, luteinizing hormone, and testosterone levels, clinically significant in a man with baggy scrotal skin and small‑appearing testes?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 22, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Your Sperm Parameters and Hormone Levels Are Reassuring

The modest drop in sperm concentration from 55 to 43 million/mL over two months is not clinically significant, and your hormone profile (FSH 9.8, LH 7.2, testosterone 40 nmol/L) indicates preserved testicular function with normal spermatogenesis. 1

Understanding Your Sperm Count

Your current sperm concentration of 43 million/mL substantially exceeds the WHO lower reference limit of 16 million/mL, placing you well within the normal fertile range. 2 The 12 million/mL decrease you observed falls within normal biological variation—sperm parameters naturally fluctuate by 20–30% between samples due to abstinence duration, illness, stress, and measurement variability. 2 Single comparisons between two analyses can be misleading, which is why repeat testing over 6–12 months is recommended to establish true trends rather than reacting to normal fluctuation. 2

Your Hormone Profile Indicates Normal Testicular Function

FSH Level of 9.8 IU/L

Your FSH sits in the upper-normal range but does not indicate testicular failure. While research shows that FSH >7.6 IU/L is associated with a five- to thirteen-fold higher risk of abnormal sperm parameters compared to FSH <2.8 IU/L 3, this statistical association applies to populations with documented oligospermia or azoospermia—not to men like you with sperm counts exceeding 40 million/mL. 2

The critical distinction: FSH >7.6 IU/L predicts non-obstructive azoospermia only when accompanied by testicular atrophy and absent or severely reduced sperm production. 2 Your documented normal sperm count of 43 million/mL confirms that your testes are producing sperm effectively despite the borderline-elevated FSH. 2

LH and Testosterone Levels

Your LH of 7.2 IU/L (upper-normal range) and testosterone of 40 nmol/L (high-normal to elevated) argue strongly against primary testicular failure. 2 In primary testicular dysfunction, you would expect both LH and FSH to be markedly elevated with low testosterone—a pattern you do not have. 2 Your hormone profile instead suggests mild compensatory pituitary stimulation with preserved Leydig cell function and adequate testosterone production. 2

Addressing Your Physical Concerns

Baggy Scrotal Skin

Scrotal skin laxity is a normal anatomical variant influenced by temperature regulation, age, and individual anatomy. It does not correlate with testicular function or sperm production. 1 The cremasteric reflex causes the scrotum to contract in cold environments and relax in warm conditions—this is protective physiology, not pathology.

Small-Appearing Testicles

Testicular volume is the critical measurement, not subjective appearance. Volumes below 12 mL are definitively considered atrophic and associated with impaired spermatogenesis, elevated FSH, and increased risk of intratubular germ cell neoplasia. 1 However, you have not reported measured testicular volumes.

If you are concerned about testicular size:

  • Obtain formal measurement using a Prader orchidometer during physical examination or scrotal ultrasound with three perpendicular dimensions (length, width, height) to calculate volume using the Lambert formula: Length × Width × Height × 0.71. 1
  • Testicular volumes ≥15–18 mL are associated with normal spermatogenesis and adequate fertility potential. 1
  • A size discrepancy between testes >2 mL or 20% warrants ultrasound evaluation to exclude pathology such as varicocele or masses. 1

What You Should Do Next

Monitor, Don't Panic

  • Repeat semen analysis in 3–6 months to establish whether your parameters are stable or declining, as single comparisons are unreliable. 2
  • If your sperm concentration remains >20 million/mL on repeat testing, no further intervention is needed. 2

Physical Examination

Schedule evaluation by a urologist or male reproductive specialist to assess:

  • Testicular volume using a Prader orchidometer (volumes <12 mL require further workup). 1
  • Presence of varicocele on standing examination—palpable varicoceles with abnormal semen parameters are an indication for surgical repair. 4
  • Testicular consistency and epididymal/vas deferens abnormalities. 2

Protect Your Fertility

  • Avoid exogenous testosterone or anabolic steroids completely—these suppress FSH and LH through negative feedback, causing azoospermia that can take months to years to recover. 2
  • Optimize modifiable factors: smoking cessation, maintain healthy body weight (BMI <25), minimize heat exposure to the testes (avoid hot tubs, prolonged sitting, laptop use on lap). 2
  • Consider sperm cryopreservation only if follow-up semen analysis shows declining concentration approaching 20 million/mL or dropping below 5 million/mL. 2

When to Worry

Seek urgent urology referral if:

  • Palpable testicular mass develops. 1
  • Rapid testicular atrophy occurs (>2 mL volume loss over 6 months). 1
  • Sperm concentration drops below 5 million/mL on repeat testing—this would trigger genetic testing (karyotype and Y-chromosome microdeletion analysis). 2

Common Pitfalls to Avoid

  • Do not overinterpret single semen analyses—natural variability of 20–30% is expected. 2
  • Do not assume FSH elevation equals testicular failure—your normal sperm count proves otherwise. 2
  • Do not start testosterone therapy if you desire current or future fertility—it will suppress spermatogenesis. 2
  • Do not delay female partner evaluation if you are actively trying to conceive—female age is the most critical factor determining conception success. 2

References

Guideline

Testicular Size and Volume Measurement

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Non-Obstructive Azoospermia Causes and Diagnosis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Risk of Azoospermia in Grade 3 Varicocele

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Related Questions

Should a 30-year-old male with normal sperm count and motility but elevated Follicle-Stimulating Hormone (FSH) levels freeze sperm for future conception?
With a follicle-stimulating hormone (FSH) level of 9.6, which is within the normal range, and a sperm count of 70 million per milliliter, am I at risk of sperm decline?
Should a male with normal sperm count (60 million per milliliter) and motility (80%), slightly elevated Follicle-Stimulating Hormone (FSH) level (10.2), and normal testicle sizes (12ml and 13ml) be concerned about his fertility?
Given bilateral testicular volume of 10 mL, follicle‑stimulating hormone 9.9 IU/L (reference 1–12.4 IU/L), and two semen analyses showing sperm concentrations of 56 million/mL and 43 million/mL, is this decline normal variation or should I be concerned about a progressive decrease in sperm count?
Can Follicle-Stimulating Hormone (FSH) levels be temporarily elevated in men and should they be rechecked?
Which of the following is not a pharmacologic function of acetaminophen?
Does levetiracetam decrease glutamate content in presynaptic vesicles?
What is the recommended management for allergic rhinitis in a 5-year-old girl with sneezing, itchy eyes, and nasal congestion?
Which receptor type do opioids bind to to produce their effects?
For a neonate (≥34 weeks gestation), when is ondansetron indicated, what is the recommended dose and dosing interval, and what monitoring and contraindications are required, particularly in preterm infants (<34 weeks) or infants weighing <2 kg?
How does levetiracetam reduce excitatory glutamate release—by decreasing presynaptic vesicle fusion via SV2A binding rather than depleting vesicular glutamate?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.